Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02526576 · ClinicalTrials.gov registry record · Phase 2
Adipose Derived Stem Cells in Facial Fat Grafting
A Phase 2 study, sponsored by Antria.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT02526576 is a Phase 2 study that has completed, run by Antria. The registered enrollment target is 34 participants.
The verdict
NCT02526576, a Phase 2 study, has completed, sponsored by Antria.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
This phase two, randomized, double-blind study is designed to demonstrate the enhanced efficacy of SVF-enriched autologous facial fat grafts, in relation to standard, non-SVF enriched, facial fat grafts by evaluating volumetric retention and contour of the engrafted region over the course of one year.
Interventions
- PROCEDURE Biopsy
- BIOLOGICAL Stromal Vasular Fraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02526576
The ClinicalTrials.gov registry entry for NCT02526576 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antria, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biopsy is the first listed.
NCT02526576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02526576 about?
NCT02526576 is a clinical study titled "Adipose Derived Stem Cells in Facial Fat Grafting". This phase two, randomized, double-blind study is designed to demonstrate the enhanced efficacy of SVF-enriched autologous facial fat grafts, in relation to standard, non-SVF enriched, facial fat grafts by evaluating volumetric retention and contour of the engrafted region over the course of one yea...
What is the current status of trial NCT02526576?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2015-08. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02526576?
The interventions under investigation include: Biopsy (PROCEDURE), Stromal Vasular Fraction (BIOLOGICAL).
Who is sponsoring clinical trial NCT02526576?
This trial is sponsored by Antria, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.